Related Experiment Video
Updated: Jun 11, 2025

Pre-clinical Model of Cardiac Donation after Circulatory Death
Published on: August 2, 2019
The Rapidly Evolving Landscape of DCD Heart Transplantation
Yashutosh Joshi1,2,3, Katherine Wang4, Campbell MacLean4
1Heart Transplantation Unit, St Vincent's Hospital Sydney, 390 Victoria St., Darlinghurst, NSW, 2010, Australia. yashutosh.joshi@svha.org.au.
Insights
Donation after circulatory death heart transplantation (DCD-HT) survival outcomes are comparable to brain dead donor heart transplantation (BDD-HT). Advancements in perfusion strategies are improving graft function and expanding DCD-HT viability.
Area of Science:
- Cardiovascular Surgery
- Transplantation Medicine
- Organ Procurement
Background:
- Donation after circulatory death (DCD) heart transplantation (HT) is an evolving field.
- Standardization of procurement strategies is crucial for optimizing outcomes.
- Advancements in organ preservation are critical for expanding the donor pool.
Purpose of the Study:
- To review international clinical outcomes of DCD-HT.
- To analyze the impact of various procurement strategies on DCD-HT outcomes.
- To explore novel approaches and future research directions in DCD-HT.
Main Methods:
- Systematic review of international clinical outcomes in DCD-HT.
- Analysis of procurement strategies, including direct procurement and regional perfusion.
- Evaluation of emerging technologies like normothermic and hypothermic machine perfusion.
Main Results:
- DCD-HT survival outcomes are comparable to brain dead donor heart transplantation (BDD-HT) across different procurement strategies.
- Normothermic machine perfusion demonstrates improved rates of primary graft dysfunction.
- Hypothermic machine perfusion shows promising early results for directly procured DCD hearts.
- Controlled cold ischemia may be tolerated, but minimizing ischemic time remains important.
Conclusions:
- DCD-HT offers survival outcomes equivalent to BDD-HT.
- Procurement strategy remains a key area for ongoing research and debate.
- Developing methods to enhance allograft tolerance to warm ischemia is vital for future advancements, particularly for machine perfusion techniques.
Purpose Of Review:
To summarise current international clinical outcomes from donation after circulatory death heart transplantation (DCD-HT); discuss procurement strategies, their impact on outcomes and overall organ procurement; and identify novel approaches and future areas for research in DCD-HT.
Recent Findings:
Globally, DCD-HT survival outcomes (regardless of procurement strategy) are comparable to heart transplantation from brain dead donors (BDD). Experience with normothermic machine perfusion sees improvement in rates of primary graft dysfunction. Techniques have evolved to reduce cold ischaemic exposure to directly procured DCD hearts, though controlled periods of cold ischaemia can likely be tolerated. There is interest in hypothermic machine perfusion (HMP) for directly procured DCD hearts, with promising early results. Survival outcomes are firmly established to be equivalent between BDD and DCD-HT. Procurement strategy (direct procurement vs. regional perfusion) remains a source of debate. Methods to improve allograft warm ischaemic tolerance are of interest and will be key to the uptake of HMP for directly procured DCD hearts.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

